PremiumRatingsOptimistic Buy Rating for Abivax SA Driven by Promising Phase 3 Developments and Market Potential Abivax completes enrollment in ABTECT trials Abivax management to meet with BTIG PremiumRatingsAbivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position Abivax SA Reports 2024 Financial Results and Advances Phase 3 Trials PremiumRatingsBuy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment Abivax Announces Share and Voting Rights Update Abivax to Host Webcast on Ulcerative Colitis Treatments and Phase 3 Trial Insights 
